## First-Line Antihypertensive in Hypertension with Diabetes **Key Point:** ACE inhibitors (or ARBs) are the first-line agents for hypertension in patients with diabetes mellitus, regardless of the presence of proteinuria or albuminuria. ### Rationale for ACE Inhibitor (Lisinopril) 1. **Renal Protection:** ACE inhibitors reduce intraglomerular pressure by dilating the efferent arteriole, providing renal protective effects independent of blood pressure lowering [cite:Harrison 21e Ch 297]. 2. **Cardiovascular Benefit:** They reduce left ventricular hypertrophy and have proven cardioprotective effects in diabetic patients. 3. **Metabolic Neutral:** Unlike thiazides, they do not adversely affect glucose metabolism or lipid profile. 4. **Evidence-Based:** Multiple guidelines (ADA, ACC/AHA) recommend ACE inhibitors or ARBs as first-line in all hypertensive diabetic patients. ### Comparison with Other Agents | Agent | Advantage in DM | Disadvantage in DM | |-------|-----------------|--------------------| | **ACE-I/ARB** | Renal protection, cardioprotection | Hyperkalemia risk (monitor) | | **Calcium Channel Blocker** | Metabolically neutral | No renal protection | | **Thiazide Diuretic** | Inexpensive | Hyperglycemia, hypokalemia | | **Beta-Blocker** | Cardioprotection if post-MI | Masks hypoglycemia, worsens glucose control | **High-Yield:** ACE inhibitors are preferred even in normotensive diabetic patients with albuminuria for renal protection. **Clinical Pearl:** If ACE inhibitor causes a dry cough (10–20% incidence), switch to an ARB, which has the same renal benefits without the cough. ## Why Lisinopril Over Alternatives Lisinopril is the gold standard because it addresses both hypertension AND provides organ protection specific to the diabetic kidney, making it the most evidence-based choice.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.